Malinga ndi lipoti lochokera ku Grand View Research "Zosowa zachipatala zosakwaniritsidwa komanso zomwe boma likuchita pofuna kuchepetsa kusokonezeka kwamisala ndi minyewa zikuyendetsa msika wamankhwala apakati amanjenje (CNS).
Malinga ndi WHO, chuma chapadziko lonse lapansi chikuchepa chifukwa cha kukhumudwa komanso nkhawa ndi ndalama zopitilira USD $ 1 thililiyoni pachaka ndipo kukwera kwa odwala matenda amisala padziko lonse lapansi kukuyembekezeka kukulitsa chuma chomwe chitayika ndi USD $ 16 thililiyoni mu 2030. Msikawu uli ndi mwayi wokulirapo wamtsogolo. ndipo osewera akulu akutenga njira zosiyanasiyana zotsatsira monga chitukuko chazinthu zatsopano, mgwirizano, kufalikira kwa malo, kuphatikiza ndi kupeza, komanso kuvomereza kwazinthu zatsopano, kuti alimbikitse maudindo awo. " Lipotilo linanena kuti kukula kwa msika wapadziko lonse lapansi wamankhwala azachipatala akuyembekezeka kufika $ 205.0 biliyoni pofika 2028 ndipo akuyembekezeka kukula pa CAGR ya 7.4% mpaka 2028.
Lipotilo linapitiliza kuti: "Kupezeka kwazinthu zamapaipi amphamvu ndi makampani akuluakulu azamankhwala ... Kupatula apo, makampani ena azamankhwala akutenga nawo gawo pakupanga zithandizo zatsopano ndikuyika ndalama zambiri kuti apange zithandizo zochizira matenda okhudzana ndi CNS. Active Biotechs m'misika lero akuphatikizapo: Pasithea Therapeutics Corp., Alkermes plc, Passage Bio, Inc., Acadia Healthcare Company, Inc., atai Life Sciences.
Mankhwala ambiri omwe amabwera mochedwa ndi ochizira matenda a neurodegenerative monga Alzheimer's, multiple sclerosis, Parkinson's disease, ndi amyotrophic lateral sclerosis… zizindikiro zosiyanasiyana za neurodegenerative. Kupatula matenda a neurodegenerative, mutu waching'alang'ala, schizophrenia, ndi khunyu ndizizindikiro zazikulu za matenda a CNS omwe ali ndi mwayi wofuna kumwa mankhwala. Makampani opanga mankhwala akutenga njira monga chitukuko cha mankhwala, kuphatikiza ndi kupeza, komanso mgwirizano kuti alimbitse malo awo pamsika. "
ZOMWE MUNGACHITE PA NKHANIYI:
- Most of the late phase development drugs are for the treatment of neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis… some of the potential drugs that could be commercialized in the next five to eight years for the treatment of various indication of neurodegenerative disorders.
- According to WHO, the global economy loses due to depression and anxiety is more than USD $1 trillion per year and rising patient base of mental health globally is expected to increase the economy loses by USD $16 trillion in 2030.
- Besides, other pharmaceutical companies are also actively involved in the development of novel therapies and investing heavily to develop effective therapeutics for the treatment of CNS associated diseases.
